November 07, 2025

ERC Synergy Grant for MPI Director Kai Johnsson

ERC Synergy Grant for MPI Director Kai Johnsson

On the trail of contacts: European Research Council funds pioneering MitoContact project to investigate communication between mitochondria and other cell components

Kai Johnsson, Director at the Max Planck Institute for Medical Research, has been awarded a Synergy Grant by the European Research Council (ERC). In the funded project MitoContact, he will work with two scientists from Switzerland to investigate how mitochondria come into contact and communicate with other cell components.

Kai Johnsson, Director at the MPI for Medical Research, receives an ERC Synergy Grant.
© MPI for Medical Research
  • ERC Synergy Grants support work on the most challenging scientific questions, which, due to their complexity, require collaboration between several researchers.
  • Kai Johnsson receives the ERC Synergy Grant together with Suliana Manley from EPFL, Lausanne, and Wanda Kukulski from the University of Bern for their joint project MitoContact.
  • The grant amounts to approximately 12 million euros over six years. The project will start in the first quarter of 2026.

“I am delighted about the ERC Synergy Grant – it is a great recognition for our team and our shared idea,” says Kai Johnsson, Director at the Max Planck Institute for Medical Research. “The funding gives us the opportunity to explore new technological approaches and take decisive steps towards a better understanding of the dynamics and functioning of membrane contact sites. In the long term, this may also open up new therapeutic avenues.”

Research team aims to understand contact sites

Mitochondria are cell components that are referred to as the “powerhouses” of cells because they produce most of the energy required by the cell. They have to meet a dual challenge: to maintain their own life cycle while supplying the entire cell with energy and signals.

The interfaces through which mitochondria come into contact and exchange information with other cell components, known as membrane contact sites, play a central role in this process. However, little is known about their diversity, organization, and functioning.

Recorder proteins developed to record cell activities

This is where the joint project MitoContact, now funded by an ERC Synergy Grant, comes in: With their research, the team led by Suliana Manley, Wanda Kukulski, and Kai Johnsson aims to gain a deeper understanding of the role of membrane contact sites. To this end, the three scientists will combine and further develop the various methods they have already developed in their laboratories. Kai Johnsson develops chemical-biological tools and fluorophores for functional cell and organism studies at the Max Planck Institute for Medical Research. One such tool is novel sensor proteins that can record cellular events like a high-resolution recorder and enable subsequent evaluation. These recorders can be specifically targeted at membrane contact sites and significantly advance research in this area.

Joining forces for a common research goal

The President of the European Research Council Maria Leptin says: “Collaboration is at the heart of the ERC Synergy Grants. In our latest round, teams of researchers will join forces to address the most complex scientific problems together – this time, they are more international than ever. The competition was fierce, with many outstanding proposals left unfunded.”

About the ERC

The ERC, set up by the European Union in 2007, is the premier European funding organization for excellent frontier research. It funds creative researchers of any nationality and age, to run projects based across Europe. The ERC offers four core grant schemes: Starting Grants, Consolidator Grants, Advanced Grants and Synergy Grants. With its additional Proof of Concept Grant scheme, the ERC helps grantees to bridge the gap between their pioneering research and early phases of its commercialization. The ERC is led by an independent governing body, the Scientific Council. Since November 2021 Maria Leptin has been the President of the ERC. The overall ERC budget from 2021 to 2027 is more than 16 billion euros, as part of the Horizon Europe program, under the responsibility of European Commissioner for Startups, Research and Innovation, Ekaterina Zaharieva.

Our latest News

discover more
AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

NORTH CHICAGO, Ill., July 6, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on results from the pivotal Phase 3 […]

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

It should be biofunctional – that is, it should replicate the natural cellular environment as closely as possible – and it should be printable: bioink. Achieving both of these properties at the same time is an enormous challenge that conventional biomaterials often fail to meet. Together with two partner companies, researchers at the NMI have now taken an important […]

New AI System Provides Treatment Recommendations for Complex Blood Cancers

New AI System Provides Treatment Recommendations for Complex Blood Cancers

Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute, and the Heidelberg University Hospital (UKHD) have developed “HemaGuide,” an AI assistant that supports physicians in making difficult treatment decisions. In extensive testing, the system has shown a high degree of agreement with the recommendations of experienced experts and could significantly improve […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp